SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043699
Filing Date
2021-08-12
Accepted
2021-08-12 10:26:47
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q freq-10q_20210630.htm   iXBRL 10-Q 2677289
2 EX-31.1 freq-ex311_9.htm EX-31.1 20271
3 EX-31.2 freq-ex312_6.htm EX-31.2 20239
4 EX-32.1 freq-ex321_7.htm EX-32.1 9772
5 EX-32.2 freq-ex322_8.htm EX-32.2 9795
  Complete submission text file 0001564590-21-043699.txt   7456294

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA freq-20210630.xsd EX-101.SCH 43544
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE freq-20210630_cal.xml EX-101.CAL 38075
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE freq-20210630_def.xml EX-101.DEF 157468
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20210630_lab.xml EX-101.LAB 372338
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20210630_pre.xml EX-101.PRE 281946
11 EXTRACTED XBRL INSTANCE DOCUMENT freq-10q_20210630_htm.xml XML 1100197
Mailing Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY, SUITE 203 WOBURN MA 01801 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 211165896
SIC: 2834 Pharmaceutical Preparations